Hudson Technologies Reports Third Quarter 2026 Results

Hudson’s profits and margins fell sharply as refrigerant prices and demand weakened.

What the company is saying

Hudson Technologies reports a challenging third quarter, highlighting a 9% decrease in sales volume and a 17% drop in selling prices, which drove revenue down to $59.4 million from $74.0 million a year ago. Management, led by President and CEO Ken Gaglione, frames the narrative around disciplined cost control and strategic investments, including a new joint development agreement with Icorium for advanced separation technology. The company stresses its continued leadership in the market and points to a 9% volume growth over the nine-month selling season, despite pricing headwinds. Gross margin for the quarter was 25%, down from 32% last year, with the company attributing this to lower refrigerant market pricing and increased operating costs. SG&A expenses rose to $10.8 million from $8.9 million, reflecting ongoing investment in ERP optimization and staffing for long-term initiatives. Net income for the quarter dropped to $2.0 million ($0.05 per share) from $12.4 million ($0.28 per share) in Q3 2025. The company maintains confidence in its strategy, reiterating full-year 2026 gross margin guidance in the low-to-mid-twenty percent range.

What the data suggests

The disclosed figures show a marked deterioration in Hudson’s financial performance. Third-quarter revenue fell 20% year-over-year to $59.4 million, with gross margin compressing to 25% from 32% as both sales volume and pricing declined. Net income plunged to $2.0 million ($0.05 per share) from $12.4 million ($0.28 per share), reflecting both weaker top-line results and higher operating expenses. For the nine months ended September 30, 2026, revenue was $197.9 million, down from $202.2 million, and net income was $7.3 million ($0.17 per share) versus $25.3 million ($0.58 per share) last year. SG&A expenses increased to $32.8 million from $26.3 million, driven by investments in ERP systems, staffing, and consulting. The company ended the quarter with $35.3 million in cash and no debt, providing some financial flexibility. Management’s explanation for the declines—lower refrigerant prices and muted demand as inventories normalized post-2025 supply chain constraints—is consistent with the data. The joint development agreement with Icorium is at an early stage, with no quantified impact yet.

Analysis

The announcement is primarily a factual disclosure of quarterly and nine-month financial results, with comprehensive figures for revenue, gross margin, net income, and expenses. The tone is neutral, and the majority of claims are realised and supported by numerical data. The only forward-looking elements are the company's ongoing gross margin guidance and the joint development agreement with Icorium, which is described as having potential but with no immediate quantified impact. There is some positive framing around operational progress and strategic positioning, but these are not overstated relative to the evidence. The capital outlays mentioned (ERP, staffing, consulting) are modest and do not represent large, long-dated investments with uncertain returns. The gap between narrative and evidence is minimal, as the release is transparent about year-over-year declines in financial performance.

Risk flags

• ●Hudson’s profitability is highly exposed to refrigerant market pricing, which declined 17% year-over-year and drove both revenue and margin deterioration. This cyclical risk is largely outside management’s control and could persist if market conditions remain weak.
• ●Operating expenses are rising, with SG&A up 21% for the nine-month period due to ongoing investments in ERP, staffing, and consulting. If revenue and margins do not recover, these higher fixed costs could further pressure earnings.
• ●The joint development agreement with Icorium is at a formative stage, with no disclosed timeline or quantifiable benefits. Execution risk exists if the technology does not deliver the expected efficiency gains or if commercialization is delayed.
• ●While the company maintains a debt-free balance sheet and $35.3 million in cash, cash from operations fell sharply to $4.3 million for the nine months, raising questions about the sustainability of self-funding future investments if market conditions do not improve.

Bottom line

Hudson Technologies’ Q3 results confirm significant margin and earnings pressure from lower refrigerant prices and soft demand, with net income dropping over 80% year-over-year. The company is investing in technology and capacity for future growth, but these initiatives have yet to deliver measurable financial benefits. Management’s narrative is credible and transparent about the causes of the downturn, but the near-term outlook remains tied to volatile market pricing. The strong cash position and lack of debt provide a buffer, but rising operating expenses and weak cash flow highlight the need for a market recovery or successful execution of new initiatives. Investors should watch for evidence of margin stabilization or tangible results from the Icorium partnership as the next key catalysts. The most important takeaway is that Hudson’s results are currently driven by external market forces, and recovery will depend on factors largely outside its control.

Announcement summary

(NASDAQ:HDSN) Hudson Technologies, Inc. announced financial results for the third quarter and nine-month period ended September 30, 2026. The company entered into a joint development agreement with Icorium for advanced next-generation separation technology aimed at enabling more efficient separation of complex, mixed refrigerants. Hudson made progress in expanding its operating capacity and capabilities during the quarter. For the third quarter of 2026, revenue was $59.4 million, compared with $74.0 million in the third quarter of 2025, reflecting a 9% decrease in sales volume and a 17% decrease in selling prices. Gross margin for the quarter was 25%, compared with 32% in the prior-year period. Selling, general and administrative expenses were $10.8 million, up from $8.9 million in the third quarter of 2025, due to continued investment in ERP optimization and additional staffing and consulting resources. Net income for the quarter was $2.0 million, or $0.05 per basic and diluted share, compared with $12.4 million, or $0.28 per basic and $0.27 per diluted share, in the third quarter of 2025. For the nine months ended September 30, 2026, revenue was $197.9 million, compared with $202.2 million in the first nine months of 2025. The company achieved 9% sales volume growth, offset by a 9% decline in selling prices. Gross margin for the nine-month period was 24%, compared with 29% in the prior-year period. Selling, general and administrative expenses for the nine months were $32.8 million, up from $26.3 million in 2025, reflecting increased operational, legal, staffing, and consulting investments. Net income for the nine months was $7.3 million, or $0.17 per basic and diluted share, compared with $25.3 million, or $0.58 per basic and $0.56 per diluted share, in the first nine months of 2025. As of September 30, 2026, Hudson reported $35.3 million in cash and cash equivalents. The company continues to expect full-year 2026 gross margin in the low-to-mid-twenty percent range. At September 30, 2026, total assets were $319,826,000 and total liabilities were $74,302,000. The company had 42,088,547 shares of common stock issued and outstanding as of September 30, 2026. Hudson Technologies will host a conference call and webcast on October 28, 2026, at 5:00 p.m. Eastern Time to discuss these results. Ken Gaglione is President and Chief Executive Officer of Hudson Technologies. Brian J. Bertaux is Chief Financial Officer and Secretary.

Disagree with this article?